Related Experiment Video
Updated: Jun 16, 2025
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.3K
Clearance Pathways for α-Synuclein in Parkinson's Disease
1Institute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Journal of Neurochemistry
|June 13, 2025
Summary
Protein aggregates like alpha-synuclein are key in Parkinson's disease. This review explores how cells clear these toxic proteins, revealing potential therapeutic targets for Parkinson's disease treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Protein aggregation, specifically alpha-synuclein, is central to Parkinson's disease pathogenesis.
- Alpha-synuclein aggregates in Lewy bodies and neurites correlate with neuronal dysfunction and loss.
- The precise mechanisms for alpha-synuclein aggregate formation, spread, and clearance are not fully understood.
Purpose of the Study:
- To review cellular and molecular pathways involved in eliminating protein aggregates in neurodegenerative diseases.
- To discuss the degradation mechanisms of alpha-synuclein in neurons and glial cells during disease progression.
- To identify potential therapeutic strategies targeting protein aggregate clearance in Parkinson's disease.
Main Methods:
- Review of experimental models of alpha-synuclein pathology.
- Analysis of cellular and molecular degradation pathways.
- Examination of cell type-specific clearance mechanisms.
Main Results:
- Summarized various experimental models of alpha-synuclein pathology.
- Discussed degradation mechanisms in neurons and glial cells.
- Highlighted cell type-specific clearance pathways.
Conclusions:
- Understanding protein aggregate clearance is crucial for neurodegenerative disease research.
- Cellular and molecular pathways offer potential therapeutic targets for Parkinson's disease.
- Targeting alpha-synuclein clearance may mitigate neurotoxicity and disease progression.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
5.9K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.5K
Related Concept Videos
01:15Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:24Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
03:03Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K